K76.6
Conditions
Interventions
Group 1: Before dilating the access route using a balloon catheter and placing the stent shunt, in addition to the standard procedure currently used at the University Hospital Magdeburg, a 10 ml solut
Sponsors
Klinik für Radiologie und Nuklearmedizin, Universitätsklinikum Magdeburg
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: - Written informed consent to participate in all study procedures - Ascites drainage performed no later than 48 hours prior to the procedure
Exclusion criteria
Exclusion criteria: - Allergies to contrast agents or other substances to be injected - Intrahepatic cholestasis; bilirubin > 4× ULN, unless there is an emergency indication - Severe pulmonary arterial hypertension (PAH > 45 mmHg), left ventricular function grade I, NT-proBNP > 1000 ng/ml - Polycystic liver disease - Current or previous hepatic encephalopathy > grade II - MELD score > 20 - FIPS score = 0.92 - Age > 80 years - Acute infections, local or systemic (e.g., signs of infection such as fever = 38.0 °C, leukocytosis = 12 Gpt/l), unless there is an emergency indication - Mechanical ileus - Pathologies in the region of the hepatic hilum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction during the intervention and all associated risks/consequences. Pain will be assessed using a Numerical Rating Scale (NRS) and the Adult Non-Verbal Pain Scale (NVPS), standardized according to the WHO-5 Well-Being Index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post-interventional reduction in non-opioid and opioid analgesic consumption. | — |
Countries
Germany
Contacts
Public ContactMarilena Georgiades
Klinik für Radiologie und Nuklearmedizin
Outcome results
None listed